Riley Reiff

Left Tackle

Age: 33
Free Agency: 2022 (Void)
Accrued Seasons: 9
  • 2021 Salary Cap Charge: $4,714,706 (2.43% of cap)
  • 2021 Cash Payout: $7,500,000 (3.49% of spending)
  • 2021 Cash to Cap Ratio: 1.59
  • Contract Value: $7,500,000 ($7,500,000 APY)
  • Fully Guaranteed Money: $5,500,000
  • Contract Ranking: 20/103 at LT

Current Contract

(SFA, signed 2021)
(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryProrated BonusPer Game Roster BonusCap
Number
Cap %
Dead Money & Cap Savings
202133$1,700,000$2,750,000$300,000$4,714,7062.4%
2022 📝
February 10: Contract voids
34Void$2,750,000Void$2,750,0001.3%
Total$1,700,000$5,500,000$300,000$7,464,706

Contract Notes

Riley Reiff signed a one year contract worth $7.5 million with the Bengals. Reiff received a $5.5 million signing bonus. There is a void year for cap purposes. That will void five days after the Super Bowl.

Cash Flows

- fully earned money
- unearned or partially earned money
$7.5M
2021
Cash Due$7,500,000
Running Cash$7,500,000
Career Earnings: $65,563,700
Career APY: $7,284,856
Potential Earnings: $66,563,700
Total Guarantees: $44,213,650
Largest Cash Payment: $17,300,000 (2017)
Largest Cap Number: $11,700,000 (2019)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
LionsDraftedExpired20125$16,063,700$3,212,740$6,513,650$16,063,700100.0%$3,212,740
VikingsUFARenegotiated20175$58,750,000$11,750,000$26,300,000$36,000,00061.3%$12,000,000
VikingsOtherTerminated20202$17,750,000$8,875,000$5,900,000$7,000,00039.4%$7,000,000
BengalsSFAActive20211$7,500,000$7,500,000$5,500,000$5,500,00073.3%$0
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money
Lions5$16,063,700$3,212,740$16,063,7000.0%$00.0%
Vikings4$44,000,000$11,000,000$39,800,0000.0%$3,200,0000.0%
Bengals0$5,500,000$0$00.0%$00.0%

Season History

YearTeamBase SalaryProrated BonusRoster BonusPer Game Roster BonusWorkout BonusGuaranteed SalaryCap
Number
Cap %Cash Paid
2012Lions$390,000$1,063,400$0$0$0$0$1,453,4001.2%$4,643,600
2013Lions$753,350$1,063,400$0$0$0$753,350$1,816,7501.5%$753,350
2014Lions$1,116,700$1,063,400$0$0$0$1,116,700$2,180,1001.7%$1,116,700
2015Lions$1,155,050$1,063,400$325,000$0$0$0$2,543,4501.8%$1,480,050
2016Lions$8,070,000$0$0$0$0$8,070,000$8,070,0005.2%$8,070,000
2017Vikings$6,200,000$2,200,000$0$0$100,000$6,200,000$8,500,0005.0%$17,300,000
2018Vikings$9,100,000$2,200,000$0$0$100,000$9,100,000$11,400,0006.0%$9,200,000
2019Vikings$9,400,000$2,200,000$0$0$100,000$0$11,700,0006.1%$9,500,000
2020Vikings$5,900,000$2,200,000$0$0$100,000$0$8,200,0004.1%$7,000,000
2021Bengals$1,700,000$2,750,000$0$300,000$0$0$4,714,7062.4%$7,500,000
2022Bengals$0$2,750,000$0$0$0$0$2,750,0001.3%$0
Total$43,785,100$18,553,600$325,000$300,000$400,000$25,240,050$63,328,406$66,563,700
Dead Money History
TeamYearCap ChargeCash Paid
Vikings2021$3,200,000$1,000,000
Total$3,200,000$1,000,000

Statistics

YearGames PlayedGames MissedSnaps
InjuredHealthyOffenseSpecial
201216----27.2%20.0%
2013160097.3%13.3%
2014150186.1%12.8%
2015160099.6%13.8%
2016141185.7%14.2%
2017151090.1%13.2%
2018133075.5%9.6%
2019150185.8%14.6%
2020150092.6%14.0%

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Regular$13,962,000$7,500,000
Injury Adjusted$13,962,000$7,500,000
test
OTC Valuation $3.1M $6.1M $9.2M $12.3M $15.3M APY $3.8M $7.7M $11.5M $15.3M $19.2M $10,803,000 $11,500,000

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.